Flottant Libre 77,58 %
Actions en Flottant 135,51 M
Actions en Circulation 174,66 M
INTELGENX TECHNOLOGIES
Action · US45822R1014 · A0RP0X (XTSX)
Pas de cours
n/a
Flottant et Liquidité des Actions
Allocation d'actifs
| Actif | Part % |
|---|---|
| Bond | 93,42 % |
| NotClassified | 5,29 % |
| Cash | 1,29 % |
| Stock non-US | 0,00 % |
| Other | 0,00 % |
| Stock US | 0,00 % |
Les plus grandes positions
| Symbole | ISIN | Nom | Part % |
|---|---|---|---|
| BOEING CO SR UN.. | 2,84 % | ||
| BANK OF AMERICA.. | 2,77 % | ||
| AT+T INC SR UNS.. | 2,17 % | ||
| CREDIT SUISSE G.. | 1,94 % | ||
| MORGAN STANLEY .. | 1,91 % | ||
| STATE STREET IN.. | 1,86 % | ||
| BAT CAPITAL COR.. | 1,84 % | ||
| WELLS FARGO + C.. | 1,78 % | ||
| JPMORGAN CHASE .. | 1,77 % | ||
| ANHEUSER BUSCH .. | 1,71 % |
Répartition par régions
| Région | Part % |
|---|---|
| Africa/Middle East | 0,00 % |
| Asia Developed | 0,00 % |
| Asia Emerging | 0,00 % |
| Australasia | 0,00 % |
| Europe Developed | 0,00 % |
| Europe Emerging | 0,00 % |
| Japan | 0,00 % |
| Latin America | 0,00 % |
| North America | 0,00 % |
| United Kingdom | 0,00 % |
Répartition par secteurs
| Secteur | Part % |
|---|---|
| Grundstoffe | 0,00 % |
| Verbrauchsgüter | 0,00 % |
| Finanzdienstleistungen | 0,00 % |
| Immobilien | 0,00 % |
| Telekommunikation | 0,00 % |
| Energie | 0,00 % |
| Industrieunternehmen | 0,00 % |
| Technologie | 0,00 % |
| Basiskonsumgüter | 0,00 % |
| Gesundheitswesen | 0,00 % |
Profil de l'entreprise pour INTELGENX TECHNOLOGIES Action
IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine; INT0046/2018 for adult use; INT0007/2006, an oral film product for treatment of erectile dysfunction; INT0043/2015, an oral film containing montelukast for treatment of Alzheimer; INT0027/2011 to treat opioid addition; INT0010/2006 for treatment of neuropathic pain and nausea in cancer patients undergoing chemotherapy; INT0036/2013, an oral film product for schizophrenia or bipolar 1 disorder; and INT0048/2020 for animal health. It is also developing INT0039/2013, INT0040/2014, INT0052/2020, INT0053/2020, and INT0054/2020. The company has licensing, development, and supply agreement with Tilray, Inc.; and development agreement with Cynapsus Therapeutics Inc. IntelGenx Technologies Corp. was founded in 2003 and is headquartered in Montreal, Canada.
Données de base du fonds
Émetteur Principal
Type de titre ETF
Nom Principal Exchange-Traded Funds - Principal Investment Grade Corporate Active ETF
Devise du fonds USD
Catégorie Corporate Bond
Notation Morningstar 4
Chiffres clés du fonds
Taille du fonds 486.880,38 EUR
Stratégie d'investissement
The investment seeks to provide current income and, as a secondary objective, capital appreciation. The fund is an actively managed exchange-traded fund (ETF) that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets, plus any borrowings for investment purposes, in investment grade corporate bonds and other fixed income securities at the time of purchase. Investment grade securities are rated BBB- or higher by S&P Global Ratings (S&P Global) or Baa3 or higher by Moody's Investors Service, Inc. (Moody's) or, if unrated, of comparable quality in the opinion of those selecting such investments.
Données de l'entreprise
Nom INTELGENX TECHNOLOGIES
Société IntelGenx Technologies Corp.
Site web
https://www.intelgenx.com
Marché d'origine 
TSX-V
TSX-V
WKN A0RP0X
ISIN US45822R1014
Type de titre Action
Secteur Healthcare
Industrie Biotechnology
PDG Dwight Gorham
Capitalisation boursière 42 Mio
Pays Canada
Devise EUR
Employés -
Adresse 6420 Abrams, H4S 1Y2 Montreal
Date d'introduction en bourse 2008-05-27
Symboles boursiers
| Nom | Symbole |
|---|---|
| TSX | IGX.TO |
Autres actions
Les investisseurs qui détiennent INTELGENX TECHNOLOGIES ont également les actions suivantes dans leur portefeuille :
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles.
Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
